VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $394,072 | -32.3% | 50,848 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $582,210 | +117.5% | 50,848 | +46.5% | 0.00% | +100.0% |
| Q1 2023 | $267,683 | +61.5% | 34,719 | +27.8% | 0.00% | 0.0% |
| Q4 2022 | $165,743 | +102846.0% | 27,171 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $161 | -99.9% | 27,171 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $161,000 | -22.2% | 27,171 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $207,000 | +179.7% | 27,171 | 0.0% | 0.00% | – |
| Q4 2021 | $74,000 | +4.2% | 27,171 | 0.0% | 0.00% | – |
| Q3 2021 | $71,000 | – | 27,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |